Logo image of CYN

CYNGN INC (CYN) Stock Fundamental Analysis

NASDAQ:CYN - Nasdaq - US23257B3050 - Common Stock - Currency: USD

4.26  -0.07 (-1.62%)

After market: 4.2 -0.06 (-1.41%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to CYN. CYN was compared to 284 industry peers in the Software industry. While CYN has a great health rating, there are worries on its profitability. While showing a medium growth rate, CYN is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year CYN has reported negative net income.
In the past year CYN has reported a negative cash flow from operations.
In the past 5 years CYN always reported negative net income.
In the past 5 years CYN always reported negative operating cash flow.
CYN Yearly Net Income VS EBIT VS OCF VS FCFCYN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -5M -10M -15M -20M -25M

1.2 Ratios

CYN has a Return On Assets of -126.80%. This is amonst the worse of the industry: CYN underperforms 90.49% of its industry peers.
The Return On Equity of CYN (-139.44%) is worse than 76.76% of its industry peers.
Industry RankSector Rank
ROA -126.8%
ROE -139.44%
ROIC N/A
ROA(3y)-115.88%
ROA(5y)-101.42%
ROE(3y)-182.19%
ROE(5y)-146.11%
ROIC(3y)N/A
ROIC(5y)N/A
CYN Yearly ROA, ROE, ROICCYN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -50 -100 -150 -200 -250

1.3 Margins

CYN does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CYN Yearly Profit, Operating, Gross MarginsCYN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K

More info and screens

7

2. Health

2.1 Basic Checks

CYN does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CYN has more shares outstanding
The number of shares outstanding for CYN has been increased compared to 5 years ago.
CYN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CYN Yearly Shares OutstandingCYN Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50K 100K 150K
CYN Yearly Total Debt VS Total AssetsCYN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

CYN has an Altman-Z score of -11.45. This is a bad value and indicates that CYN is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of CYN (-11.45) is worse than 88.03% of its industry peers.
CYN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -11.45
ROIC/WACCN/A
WACC9.05%
CYN Yearly LT Debt VS Equity VS FCFCYN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 10M -10M 20M -20M

2.3 Liquidity

A Current Ratio of 8.49 indicates that CYN has no problem at all paying its short term obligations.
The Current ratio of CYN (8.49) is better than 92.61% of its industry peers.
CYN has a Quick Ratio of 8.08. This indicates that CYN is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 8.08, CYN belongs to the top of the industry, outperforming 92.61% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 8.49
Quick Ratio 8.08
CYN Yearly Current Assets VS Current LiabilitesCYN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

More info and screens

6

3. Growth

3.1 Past

CYN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 80.02%, which is quite impressive.
CYN shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -34.00%.
Measured over the past years, CYN shows a very strong growth in Revenue. The Revenue has been growing by 25.13% on average per year.
EPS 1Y (TTM)80.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.63%
Revenue 1Y (TTM)-34%
Revenue growth 3YN/A
Revenue growth 5Y25.13%
Sales Q2Q%752.99%

3.2 Future

The Earnings Per Share is expected to grow by 28.40% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 168.10% on average over the next years. This is a very strong growth
EPS Next Y99.61%
EPS Next 2Y41.38%
EPS Next 3Y28.4%
EPS Next 5YN/A
Revenue Next Year164.13%
Revenue Next 2Y273.38%
Revenue Next 3Y168.1%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CYN Yearly Revenue VS EstimatesCYN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2022 2023 2024 2025 2026 2027 10M 20M 30M
CYN Yearly EPS VS EstimatesCYN Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 -5K -10K -15K -20K

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

CYN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year CYN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CYN Price Earnings VS Forward Price EarningsCYN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CYN Per share dataCYN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -500 -1K -1.5K

4.3 Compensation for Growth

CYN's earnings are expected to grow with 28.40% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.38%
EPS Next 3Y28.4%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CYN!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CYNGN INC

NASDAQ:CYN (6/16/2025, 8:00:01 PM)

After market: 4.2 -0.06 (-1.41%)

4.26

-0.07 (-1.62%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)05-07 2025-05-07/amc
Earnings (Next)08-08 2025-08-08
Inst Owners15.52%
Inst Owner Change-82.34%
Ins Owners0%
Ins Owner Change0%
Market Cap7.46M
Analysts80
Price Target12.24 (187.32%)
Short Float %2.77%
Short Ratio1.08
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-26.61%
Min EPS beat(2)-49.37%
Max EPS beat(2)-3.85%
EPS beat(4)2
Avg EPS beat(4)4.96%
Min EPS beat(4)-49.37%
Max EPS beat(4)49.13%
EPS beat(8)5
Avg EPS beat(8)0.64%
EPS beat(12)8
Avg EPS beat(12)3.35%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-57.48%
Min Revenue beat(2)-90.69%
Max Revenue beat(2)-24.26%
Revenue beat(4)0
Avg Revenue beat(4)-76.7%
Min Revenue beat(4)-98.41%
Max Revenue beat(4)-24.26%
Revenue beat(8)1
Avg Revenue beat(8)-62.72%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-92.24%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-21.78%
EPS NY rev (1m)0%
EPS NY rev (3m)99.34%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-68.54%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-11.54%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 18.19
P/FCF N/A
P/OCF N/A
P/B 0.34
P/tB 0.38
EV/EBITDA N/A
EPS(TTM)-1536.92
EYN/A
EPS(NY)-3.31
Fwd EYN/A
FCF(TTM)-6.39
FCFYN/A
OCF(TTM)-5.81
OCFYN/A
SpS0.23
BVpS12.65
TBVpS11.2
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -126.8%
ROE -139.44%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-115.88%
ROA(5y)-101.42%
ROE(3y)-182.19%
ROE(5y)-146.11%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 148.36%
Cap/Sales 247.82%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 8.49
Quick Ratio 8.08
Altman-Z -11.45
F-Score5
WACC9.05%
ROIC/WACCN/A
Cap/Depr(3y)139.74%
Cap/Depr(5y)N/A
Cap/Sales(3y)236.57%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)80.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.63%
EPS Next Y99.61%
EPS Next 2Y41.38%
EPS Next 3Y28.4%
EPS Next 5YN/A
Revenue 1Y (TTM)-34%
Revenue growth 3YN/A
Revenue growth 5Y25.13%
Sales Q2Q%752.99%
Revenue Next Year164.13%
Revenue Next 2Y273.38%
Revenue Next 3Y168.1%
Revenue Next 5YN/A
EBIT growth 1Y5.94%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year23.52%
EBIT Next 3Y32.43%
EBIT Next 5YN/A
FCF growth 1Y42.42%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y44.39%
OCF growth 3YN/A
OCF growth 5YN/A